Expertise in
18
conditions

Dr. Gary W. Falk

Gastroenterology
University Of Pennsylvania
3400 Civic Center Blvd, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
18
conditions
University Of Pennsylvania
3400 Civic Center Blvd, 
Philadelphia, PA 

Overview

Gary Falk is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Falk is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Eosinophilic Esophagitis, Esophagitis, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 225 peer reviewed articles and participating in 12 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

University of Pennsylvania
3400 Civic Center Blvd, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication of Barrett's Esophagus With Radiofrequency Ablation
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication of Barrett's Esophagus With Radiofrequency Ablation
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 2
Interscope Endorotor® Mucosal Resection System With Continued Ablative Therapy In Subjects With Refractory Dysplastic Barrett's Esophagus
Interscope Endorotor® Mucosal Resection System With Continued Ablative Therapy In Subjects With Refractory Dysplastic Barrett's Esophagus
Enrollment Status: Terminated
Publish Date: March 27, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE
Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE
Enrollment Status: Completed
Publish Date: October 22, 2025
Intervention Type: Behavioral
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Application of the Microbiome and Microenvironment to Novel Non-Endoscopic Screening and Surveillance in Barrett's Esophagus
Application of the Microbiome and Microenvironment to Novel Non-Endoscopic Screening and Surveillance in Barrett's Esophagus
Enrollment Status: Completed
Publish Date: April 05, 2024
Intervention Type: Device
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Enrollment Status: Completed
Publish Date: September 28, 2021
View 9 Less Clinical Trials

225 Total Publications

Presentation of the AGA William Beaumont Prize in Gastroenterology to Stuart Jon Spechler, MD, AGAF.
Presentation of the AGA William Beaumont Prize in Gastroenterology to Stuart Jon Spechler, MD, AGAF.
Journal: Gastroenterology
Published: September 04, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Gary R. Lichtenstein
Gastroenterology
Expertise in
17
conditions
Dr. Gary R. Lichtenstein
Gastroenterology
Referral required
Before you request

Penn Gastroenterology Perelman

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (0.1 miles away)
215-349-8222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Lichtenstein is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lichtenstein is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Viral Gastroenteritis, Crohn's Disease, Endoscopy, and Colonoscopy. Dr. Lichtenstein is board certified in Gastroenterology, 1989 and Internal Medicine, 1987. Dr. Lichtenstein is currently accepting new patients.

Expertise in
34
conditions
Dr. Thomas E. Kowalski
Gastroenterology | Hepatology
Expertise in
34
conditions
Dr. Thomas E. Kowalski
Gastroenterology | Hepatology
Referral may be required
Before you request
132 South 10th Street, 
Philadelphia, PA 
 (1.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Kowalski is a Gastroenterologist and a Hepatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Kowalski is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Jaundice, Pancreatic Pseudocyst, Endoscopy, and Gastric Bypass. Dr. Kowalski is board certified in Gastroenterology. Dr. Kowalski is currently accepting new patients.

Expertise in
29
conditions
Dr. Gregory G. Ginsberg
Gastroenterology
Expertise in
29
conditions
Dr. Gregory G. Ginsberg
Gastroenterology
Referral may be required
Before you request

Penn Gastroenterology Perelman

3400 Civic Center Boulevard, South Pavilion, 4th Floor, 
Philadelphia, PA 
 (0.1 miles away)
215-349-8222
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gregory Ginsberg is a Gastroenterologist practicing medicine in Philadelphia, Pennsylvania. Dr. Ginsberg is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Barrett Esophagus, Achalasia, Cholestasis, Endoscopy, and Colonoscopy. Dr. Ginsberg is board certified in Gastroenterology, 1993. Dr. Ginsberg is currently accepting new patients.

Frequently Asked Questions about Dr. Gary W. Falk

How do I make an appointment with Dr. Gary W. Falk?

You can book an appointment with Dr. Gary W. Falk by calling their office at 215-349-8222. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gary W. Falk a top-rated expert for Barrett Esophagus?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary W. Falk is classified as an Elite expert for Barrett Esophagus, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gary W. Falk specialize in?

While Dr. Gary W. Falk is a Gastroenterology, they have specific expertise in Barrett Esophagus, Eosinophilic Esophagitis, and Esophagitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Gary W. Falk participate in research or clinical trials?

Yes. Dr. Gary W. Falk has published 225 articles and abstracts on conditions like Barrett Esophagus. You can view a list of Dr. Gary W. Falk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gary W. Falk accept my insurance?

Dr. Gary W. Falk accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-349-8222 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Falk's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile